RXRX

RECURSION PHARMACEUTICALS-A

About RXRX

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company decoding biology by integrating technology across biology, chemistry, automation, machine learning, and engineering to industrialize drug discovery. The Company’s platform includes the Recursion Operating System, which combines an advanced infrastructure layer to generate proprietary biological and chemical datasets, and the Recursion Map, a suite of custom software, algorithms, and machine learning tools. The Company’s programs include REC-994, REC-2282, REC-4881, and REC-3599. REC-994 is an orally bioavailable, superoxide, scavenger small molecule being developed for the treatment of CCM. REC-2282 is developed for the treatment of neurofibromatosis type 2. REC-4881 is developed for the treatment of familial adenomatous polyposis. REC-3599 is developed for the treatment of GM2 gangliosidosis.

Buy US stocks in Australia starting with RXRX. Open an account and start investing today!

Market Capitalisation

$1.62B

Price-earnings ratio

Dividend yield

0.00%

Volume

732.37K

High today

$8.68

Low today

$8.15

Open price

$8.23

52-week high

$14.18

52-week low

$4.92

RXRX FAQs

How much is one share of RECURSION PHARMACEUTICALS-A?

One share of RECURSION PHARMACEUTICALS-A is valued at $8.49.

What is the ticker symbol for RECURSION PHARMACEUTICALS-A?

The ticker symbol for RECURSION PHARMACEUTICALS-A is RXRX.

How do I buy RXRX shares in Australia?

To buy RXRX stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in RXRX

What is the market capitalisation of RECURSION PHARMACEUTICALS-A RXRX?

As of 30/01/2023 RECURSION PHARMACEUTICALS-A has a market cap of $1.6B.

What is the 52-week high for RECURSION PHARMACEUTICALS-A stock?

The RECURSION PHARMACEUTICALS-A 52-week high stock price is $14.18.

What is the 52-week low for RECURSION PHARMACEUTICALS-A stock?

The RECURSION PHARMACEUTICALS-A 52-week low stock price is $4.92.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.